Demis Hassabis, cofounder of DeepMind and 2024 Nobel Laureate, talks to Fortune about his AI drug discovery startup, ...
The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...
Isomorphic Labs, an Alphabet-backed AI biotech firm, raised $600M to boost its AI drug design engine, expand clinical ...
Demis Hassabis, a childhood chess prodigy, said his experience with the game afforded him his first brush with AI. He was ...
In AI, games are more than just fun—they can reconceive what’s possible. Demis Hassabis, cofounder of DeepMind and 2024 Nobel Laureate, knows this firsthand. In 2016, after AlphaGo—the AI ...
The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...
Demis, who was last year jointly awarded the Nobel Prize in Chemistry with Google DeepMind colleague Dr John Jumper for their ...
CEOs succeed not through degrees alone, but through intelligent, emotionally aware, and team-oriented communication styles.
The funding is set to accelerate the development of Isomorphic’s AI drug design engine and advance clinical programmes.
Google reshuffles AI leadership with Sissie Hsiao stepping down and Josh Woodward stepping in to drive Gemini's evolution.